Enalapril Maleate and Hydrochlorothiazide NDC 51672-4046

NDC codes

FDA NDC Directory

Product NDC (as listed)51672-4046Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51672-4046Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51672-4046-1	51672404601	100 TABLET in 1 BOTTLE (51672-4046-1)Marketed from Sep 18, 2001
51672-4046-3	51672404603	1000 TABLET in 1 BOTTLE (51672-4046-3)Marketed from Sep 18, 2001

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Enalapril Maleate and Hydrochlorothiazide
Generic name (nonproprietary): enalapril maleate and hydrochlorothiazide
Active ingredients: Enalapril maleate — 10 mg/1Hydrochlorothiazide — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075788
Marketing start: Sep 18, 2001
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Decreased Blood Pressure (Physiologic effect)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 51672-4046_5699d24d-8bf5-0759-e063-6394a90ad9a3SPL ID 5699d24d-8bf5-0759-e063-6394a90ad9a3SPL set ID 7cb92cf2-46f2-4379-937c-168d230e43a4RxCUI 858824, 858828UNII 0J48LPH2TH, 9O25354EPJ
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672404601 followed by a unit qualifier and the quantity

Package 51672-4046-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 14, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Enalapril maleate and hydrochlorothiazide is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial treatment (see DOSAGE AND ADMINISTRATION ). In using enalapril maleate and hydrochlorothiazide, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that enalapril does not have a similar risk (see WARNINGS ). In considering use of enalapril maleate and hydrochlorothiazide, it should be noted that black patients receiving…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075788

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075788
Product	Strength	Form · route	Labeler	Product NDC
Enalapril Maleate and Hydrochlorothiazide	Enalapril maleate 5 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Sun Pharmaceutical Industries, Inc.	51672-4045